Effects of synthesis conditions and release medium pH on release properties of acyclovir – mercaptopropyl modified silica composite

References

• Herpes simplex virus. [cited 2019 Nov 27]. https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus.
   Google Scholar
• Wagstaff AJ, Faulds D, Goa KL. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1994;47(1):153–205.
   PubMed Web of Science ®Google Scholar
• Solomon T. Virus infections of the nervous system. In: Manson’s tropical infectious diseases. J. Farrar, T. Junghanss, D. Lalloo, P.J. Hotez, G. Kang, N.J. White (eds.). 23th edition. Philadelphia: Elsevier, 2014. Chp. 21. p. 242–272.
   Google Scholar
• Arnal J, Gonzalez-Alvarez I, Bermejo M, et al. Biowaiver monographs for immediate release solid oral dosage forms: aciclovir. J Pharm Sci. 2008;97(12):5061–5073.
   PubMed Web of Science ®Google Scholar
• Bremmell KE, Prestige CA. Enchancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges. Drug Dev Pharm Ind. 2019;45(3):345–358.
   Web of Science ®Google Scholar
• Mitran R-A, Deaconu M, Matei C, et al. Mesoporous silica as carrier for drug-delivery systems. In: Nanocarriers for drug delivery. S.S. Mohapatra, S. Ranjan, N. Dasgupta, R. K. Mishra, S. Thomas (eds.). The Netherlands: Elsevier; 2019. Chp. 11, p. 351–374.
   Google Scholar
• Gonçalves MC. Sol-Gel silica nanoparticles in medicine: a natural choice. Design, synthesis and products. Molecules. 2018;23(8):2021.
   PubMed Web of Science ®Google Scholar
• Saroj S, Rajput SJ. Composite smart mesoporous silica nanoparticles as promising therapeutic and diagnostic candidates: recent trends and applications. J Drug Deliv Sci Technol. 2018;44:349–365.
   Web of Science ®Google Scholar
• Qu H, Bhattacharyya S, Ducheyne P. Silicon oxide based materials for controlled release in orthopedic procedures. Adv Drug Deliv Rev. 2015;94:96–115.
   PubMed Web of Science ®Google Scholar
• Bareiss B, Ghorbani M, Li F, et al. Controlled release of acyclovir through bioengineered corneal implants with silica nanoparticle carriers. The open tis eng. TOTERMJ. 2010;3(1):10–17.
   Google Scholar
• Lee EC, Nguyen CTH, Strounina E, et al. Structure-activity relationships of GAG mimetic-functionalized mesoporous silica nanoparticles and evaluation of acyclovir-loaded antiviral nanoparticles with dual mechanisms of action. ACS Omega. 2018;3(2):1689–1699.
   PubMed Web of Science ®Google Scholar
• Tayebee R, Abdizadeh MF, Amini MM, et al. Fe3O4 @SiO2 -NH2 as an efficient nanomagnetic carrier for controlled loading and release of acyclovir. Int J Nano Dimens. 2017;8(4):365–372.
   Web of Science ®Google Scholar
• Durai RD. Drug delivery approaches of an antiviral drug: a comprehensive review. Asian J Pharm. 2015;9(1):1–12.
   Google Scholar
• Sankar R and Jain S. Approaches for enhancing the bioavailability of acyclovir: a critical review. Int J Pharm Bio Sci. 2013;4(4):623–634.
   Google Scholar
• Owens JG, Singh RK, Foroutan F, et al. Sol–gel based materials for biomedical applications. Prog Mater Sci. 2016;77:1–79.
   Web of Science ®Google Scholar
• Gupta R, Chaudhury NK. Entrapment of biomolecules in sol-gel matrix for applications in biosensors: problems and future prospects. Biosens Bioelectron. 2007;22(11):2387–2399.
   PubMed Web of Science ®Google Scholar
• Barton D, Ollis WD. Comprehensive organic chemistry. The synthesis and reactions of organic compounds. New York: Pergamon Press; 1979. Vol. 2.
   Google Scholar
• Akimsheva EY, Dolinina ES, Parfenyuk EV. Interactions of sol-gel encapsulated acyclovir with silica matrix. Colloids Surf B Biointerfaces. 2019;178:103–110.
   PubMed Web of Science ®Google Scholar
• Viitala R, Jokinen M, Rosenholm JB. Mechanistic studies on release of large and small molecules from biodegradable SiO2. Int J Pharm. 2007;336(2):382–390.
   PubMedGoogle Scholar
• Dolinina ES, Parfenyuk EV. Development of novel delivery system for cardiovascular drug molsidomine: influence of synthesis method and conditions on molsidomine release from its composites with hydrophilic silica in vitro. J Pharm Sci. 2016;105(6):1952–1959.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng S-S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res. 2003;20(11):1864–1872.
   PubMed Web of Science ®Google Scholar
• Evans DE, Pye G, Bramley R, et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988;29(8):1035–1041.
   PubMed Web of Science ®Google Scholar
• Koziolek M, Grimm M, Becker D, et al. Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap(®) system. J Pharm Sci. 2015;104(9):2855–2863.
   PubMed Web of Science ®Google Scholar
• Bruschi ML. Strategies of modify the drug release from pharmaceutical systems. Chp. 5. Cambridge: Woodhead Publishing, 2015. p. 63–86.
   Google Scholar
• Perrier Y, Rades T. Pharmaceuticals-Drug delivery and targeting. 2 edition. UK: Pharmaceutical Press, 2012. Chp. 1. P. 1–24.
   Google Scholar
• Chai T, Draxler RR. Root mean square error (RMSE) or mean absolute error (MAE)? –arguments against avoiding RMSE in the literature. Geosci Model Dev. 2014;7(3):1247–1250.
   Web of Science ®Google Scholar
• Yamaoka K, Nakagawa T, Uno T. Application of Akaike's Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978;6(2):165–175.
   PubMedGoogle Scholar
• Wang YJ, Zhu SG, Xun CF. Biochemistry. 3rd ed. Beijing, China: Higher Education Press; 2003.
   Google Scholar
• Irmukhametova GS, Mun GA, Khutoryanskiy VV. Thiolated mucoadhesive and PEGylated nonmucoadhesive organosilica nanoparticles from 3-Mercaptopropyltrimethoxysilane. Langmuir. 2011;27(15):9551–9556.
   PubMed Web of Science ®Google Scholar
• Ways TMM, Lau WM, Ng KW, et al. Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro. Eur.J Pharm Sci. 2018;122:230–238.
   PubMed Web of Science ®Google Scholar
• Juère E, Kleitz F. On the nanopore confinement of therapeutic drugs into mesoporous silicamaterials and its implications. Micropor. Mesopor. Mater. 2018;270:109–119.
   Web of Science ®Google Scholar
• Van Speybroeck M, Mellaerts R, Mols R, et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur J Pharm Sci. 2010;41(5):623–630.
   PubMed Web of Science ®Google Scholar
• Lutker KM, Quiñones R, Xu J, et al. Polymorphs and hydrates of acyclovir. J Pharm Sci. 2011;100(3):949–963.
   PubMed Web of Science ®Google Scholar
• Karolewicz B, Nartowski K, Pluta J, et al. Physicochemical characterization and dissolution studies of acyclovir solid dispersions with pluronic F127 prepared by the kneading method. Acta Pharm. 2016;66(1):119–128.
   PubMed Web of Science ®Google Scholar
• Gong CY, Shi S, Dong PW, et al. In vitro drug release behavior from a novel thermosensitive composite hydrogel based on pluronic f127 and poly(ethylene glycol)-poly(ε-caprolactone)-poly(ethylene glycol) copolymer. BMC Biotechnol. 2009;9(1):8.
   PubMedGoogle Scholar
• Kortesuo P, Ahola M, Kangas M, et al. In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters. Int J Pharm. 2001;221(1–2):107–114.
   PubMedGoogle Scholar
• Zhang S, Chu Z, Yin C, et al. Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles. J Am Chem Soc. 2013;135(15):5709–5716.
   PubMed Web of Science ®Google Scholar
• Nartowski KP, Malhotra D, Hawarden LE, et al. (19) F NMR spectroscopy as a highly sensitive method for the direct monitoring of confined crystallization within nanoporous materials. Angew Chem Int Ed Engl. 2016;55(31):8904–8908.
   PubMed Web of Science ®Google Scholar
• Su Z, Sun F, Shi Y, et al. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly (D, L -lactide-co-glycolide) microsphere. Chem Pharm Bull. 2009;57(11):1251–1256.
   PubMed Web of Science ®Google Scholar
• Qian K, Shi T, He S, et al. Release kinetics of tebuconazole from porous hollow silica nanospheres prepared by miniemulsion method. Micropor Mesopor Mater. 2013;169:1–6.
   Web of Science ®Google Scholar
• Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporationmethod. Biomaterials. 2001;22(3):231–241.
   PubMed Web of Science ®Google Scholar
• Jain S, Mittal A, Jain AK, et al. Cyclosporin a loaded PLGA nanoparticle: preparation, optimization, in-vitro characterization and stability studies. CNANO. 2010;6(4):422–431.
   Google Scholar